(Getty Images)

As 2017 comes to close, we want to take this opportunity to acknowledge the many accomplishments of our world-class faculty and staff -- the list below is but a sampling of their achievements. We look forward to sharing the latest research breakthroughs, clinical innovations, education milestones and community outreach in the new year!

• Shoukhrat Mitalipov, Ph.D., and team are first to use the gene-editing tool CRISPR to correct a disease-causing mutation in nuclear DNA/human embryos that causes hypertrophic cardiomyopathy.
• Oregon’s first 24-hour dedicated psychiatric emergency facility located in the greater Portland metropolitan area opens; the Unity Center for Behavioral Health is a collaborative effort among OHSU, Legacy, Kaiser and Adventist.
• Nature names OHSU among top 20 research institutions in the world.
• OHSU, ORPRN receive $8 million to help people with serious illnesses get the care they want.
• OHSU earns two grants totaling $62 million from the National Center for Advancing Translational Sciences, to help bridge basic science and clinical research.
• Iranian baby Fatemeh doing well following life-saving heart surgery at OHSU Doernbecher.
• OHSU, Adventist Health Portland finalize affiliation agreement.
• Nathan Selden, M.D., Ph.D., and team validate and publish training technique/courses for beginning neurosurgeons; 2017 marks the first year Society of Neurological Surgeons requires all junior neurosurgery residents to use simulator as part of their training.
• U.S. News & World Report ranks OHSU Doernbecher among the nation’s best children’s hospitals.
• U.S. News & World Report names OHSU Hospital No. 1 in Oregon, ranks seven OHSU specialties among best in the nation.
• OHSU completes $32 million fundraising campaign to build patient family guest house on Portland’s South Waterfront.
• Research led by Kim Burchiel, M.D., and team is first to indicate clinical outcomes for deep brain stimulation while patients are asleep are on par or better than surgery while awake.
• OHSU Healthcare recognized for exceptional nursing outcomes, recertified as Magnet hospital.
• OHSU Healthcare receives 2017 Vizient Bernard A. Birnbaum, M.D., Quality Leadership Award for superior quality and safety performance as measured by the Vizient Quality and Accountability Study; ranks 12^th out of 107 academic medical centers included in the report.
• Knight Cancer Institute recruits internationally renowned cancer researcher Gordon Mills, M.D., from MD Anderson Cancer Center to lead the institute’s efforts in precision oncology.
• OHSU and Columbia Memorial Hospital collaborate to bring radiation therapy to the north Oregon coast.
• OHSU is the first hospital in the nation to implement a virtual simulation tool into its clinical care program to help patients better understand, ask questions before procedures
• NIH selects the Knight Cancer Institute to co-lead the largest national database for pediatric cancer, rare disease research.
• Non-invasive eye imaging technology known as optical coherence tomography -- co-invented by Dr. David Huang -- saves the U.S. government and patients billions of dollars.
• Brian Druker, M.D., American Cancer Society and others successfully lobby to raise the smoking age in Oregon to 21.
• A first-of-its-kind vaccine technology platform developed by Dr. Louis Picker and colleagues is acquired by Vir Biotechnology, a San Francisco-based biotech startup backed by leading industry investor ARCH Venture Partners and the Bill & Melinda Gates Foundation, a leading funder of global health initiatives.
• Knight Cancer Institute earns the National Cancer Institute’s highest distinction: Comprehensive Cancer Center status.
• Technology expert Mike Heller, Ph.D., joins Knight Cancer Institute’s center for cancer early detection.
• OHSU School of Medicine is one of handful of U.S. medical schools to offer Structural Competency, a new method of teaching students and residents about social, economic, legal and cultural structures that impact health.
• Knight Cancer Institute joins a prestigious national consortium and is selected to receive $9.2 million from the NIH to study triple-negative breast cancer.
• Vinay Prasad, M.D., earns $2 million from the Laura and John Arnold Foundation to investigate health care practices that 'don’t work.’
• OHSU graduate students receive record six National Science Foundation GRFP fellowships
• The New England Journal of Medicine published a study led by Brian Druker, M.D., demonstrating long-term results of Gleevec® for patients with chronic myeloid leukemia.
• Doernbecher Children’s Hospital receives inaugural Pediatric Excellence Award from Press Ganey, which recognizes a standalone pediatric hospital, hospital within a system or unit that has demonstrated extraordinary commitment to the delivery of pediatric care.
• OHSU Knight–Legacy Health Cancer Collaborative program expands to Clark County.
• OHSU-PSU School of Public Health receives accreditation by the Council on Education for Public Health.
• Doernbecher Freestyle reaches $20 million fundraising milestone (program began in 2003).
• OHSU Doernbecher is first hospital in the Pacific Northwest to offer new FDA-approved treatment (Kymriah) for advanced leukemia.
• Sharon Anderson, M.D., named dean of OHSU School of Medicine.
• Elena Andresen, Ph.D., appointed executive vice president and provost of OHSU.
• Mitch Wasden, Ed.D., joins OHSU as executive vice president, CEO of OHSU Healthcare.